相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incorporating Receptor Theory in Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling
Bart A. Ploeger et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Impact of plasma-protein binding on receptor occupancy: An analytical description
Lambertus A. Peletier et al.
JOURNAL OF THEORETICAL BIOLOGY (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter
Fanxing Zeng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
Mark R. Dowling et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain
HV Krell et al.
PSYCHOSOMATICS (2005)
Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents
PE Hendershot et al.
PSYCHOPHARMACOLOGY (2001)
Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression
JC Fleishaker
CLINICAL PHARMACOKINETICS (2000)
Pharmacological properties of naturally occurring variants of the human norepinephrine transporter
F Runkel et al.
PHARMACOGENETICS (2000)
Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
EHF Wong et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
